How Medicare’s Aduhelm decision revived old questions about new drugs
(By Kerry Dooley Young for STAT) Medicare’s decision to withhold coverage for Biogen’s Aduhelm despite the Food and Drug Administration’s
Read moreAlzheimer's Treatment
26 state attorneys general urge Medicare to cover Alzheimer’s treatments
(By Rylee Wilson for Becker’s Hospital Review) Twenty-six state attorneys general are asking Medicare to cover monoclonal antibody treatments for
Read moreDepression And Alzheimer’s Treatments At A Crossroads
(By Jon Hamilton and Aaron Scott for NPR) Researchers are launching a make-or-break study to test the conventional wisdom about
Read more